These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8785988)

  • 1. Comparison of rocket immuno-electrophoresis (RIE) and ELISA for determination of tetanus antibodies in tetanus immunoglobulins.
    Zott A
    Dev Biol Stand; 1996; 86():348. PubMed ID: 8785988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of tetanus antibodies by the ELISA method].
    Smídová V; Kyselová M; Libichová H
    Cesk Epidemiol Mikrobiol Imunol; 1983 Mar; 32(2):87-95. PubMed ID: 6220825
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new ELISA micromethod for the determination of tetanus antibodies].
    Ambrosch F; Wiedermann G; Müller H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):173-82. PubMed ID: 6397941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of tetanus antibodies with the aid of dot-enzyme-linked immunosorbent assay (Dot-ELISA). Validation of the results using standard ELISA and passive hemagglutination test.
    Bizzini B; Leonardi MS; Zummo S; Mastroeni P
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):391-3. PubMed ID: 2152298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for serological potency testing of tetanus vaccines for human use: Clostridium tetani guinea pig antiserum (human).
    Hendriksen C; van der Gun J; Winsnes R; Urdal T; Rautmann G; Esposito-Farese ME
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):7-11. PubMed ID: 11705101
    [No Abstract]   [Full Text] [Related]  

  • 6. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use.
    Pharmeuropa Spec Issue Biol; 2002 Oct; 2001(2):1-92. PubMed ID: 11820120
    [No Abstract]   [Full Text] [Related]  

  • 7. Tetanus antibody assay combining in-house ELISA and particle agglutination test and its serosurvey application in a province in Turkey.
    Coplu N; Esen B; Gozalan A; Miyamura K; Yoshida I; Kurtoglu D; Dogan NO; Afacan G; Unal A; Ishida S; Takahashi M
    Jpn J Infect Dis; 2004 Jun; 57(3):97-102. PubMed ID: 15218217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
    Beckmann R; Gyra H; Cussler K
    Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tetanus immunity in the elderly in the Czech Republic].
    Matousková I; Máchová L; Cízek L; Janoutová G; Hosková J; Janout V
    Epidemiol Mikrobiol Imunol; 2007 Feb; 56(1):10-3. PubMed ID: 17427748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
    Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
    Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serological potency assay for Clostridium chauvoei.
    Hauer PJ; Whitaker MS; Henry LA
    Dev Biol Stand; 1996; 86():331. PubMed ID: 8785971
    [No Abstract]   [Full Text] [Related]  

  • 12. [Seroepidemiological survey on diphtheria and tetanus immunization coverage in adolescents in Calabria].
    Pavia M; Indovino A; Talarico F; Angelillo IF
    Ann Ig; 1996; 8(4):411-8. PubMed ID: 9235011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of tetanus antitoxin in human serum].
    Kamenická L; Masár I; Nováková I
    Cesk Epidemiol Mikrobiol Imunol; 1984 May; 33(3):136-41. PubMed ID: 6235929
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of antibodies against tetanus upon revaccination.
    Matousková I; Matlerová S; Janoutová G; Janout V
    Cent Eur J Public Health; 2005 Jun; 13(2):99-102. PubMed ID: 15969459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups.
    Caglar K; Karakus R; Aybay C
    Eur J Clin Microbiol Infect Dis; 2005 Aug; 24(8):523-8. PubMed ID: 16096777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Horse products for tetanus prophylaxis.
    Shindman J
    CMAJ; 1994 Jul; 151(1):16. PubMed ID: 8004555
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
    Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
    Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulins.
    Gross S; Janssen SW; de Vries B; Terao E; Daas A; Buchheit KH
    Biologicals; 2010 Jul; 38(4):501-10. PubMed ID: 20399681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inclusion of a rapid test in the current Health Ministry Guidelines with the purpose of improving anti-tetanus prophylaxis prescribed to wounded patients presenting at French Emergency Departments].
    Elkharrat D; Espinoza P; De la Coussaye J; Potel G; Pourriat JL; Sanson-Le Pors MJ
    Med Mal Infect; 2005 Jun; 35(6):323-8. PubMed ID: 15975751
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection against tetanus in the aged people in the Czech Republic--cross-sectional study.
    Janout V; Matouskova I; Machova L; Cizek L; Janoutova G; Hoskova J
    Arch Gerontol Geriatr; 2005; 40(2):123-8. PubMed ID: 15680496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.